International trade · 06/09/2011Updated: 10/17/2026 · 1 min read
U.S. International Trade Commission Denies Review of Gemcitabine Investigation
The U.S. International Trade Commission has decided not to review an initial determination that terminated an investigation into gemcitabine and products containing the same, following a motion to end the investigation entirely
Original source language: Federal Register — International Trade CommissionOpen original release →